AstraZeneca respiratory business gets boost from 3-drug inhaler results

Prospects for AstraZeneca's respiratory treatments business improved on Wednesday as a three-drug inhaler was shown to ease smoker's lung and U.S. regulators granted its injectable asthma drug Fasenra special status for a rare lung condition.

from Reuters: Health News https://ift.tt/2zsSWnG